LivaNova PLC
LivaNova PLC (LIVN) Straddle
LIVN straddle scan found 55 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 52.6%.
Read more
Trading a LIVN straddle lets you take a pure volatility position on LivaNova PLC without committing to a direction. LivaNova PLC's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LIVN straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on LIVN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when LivaNova PLC stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LIVN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea.
It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the LIVN straddle is the cleanest expression of that view. Our scanner prices every LIVN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LIVN straddle into a catalyst or short a LIVN straddle to harvest decay, the options straddle setups that matter are all in one place.
| Apr 16, 2027 | 100.00 | $26.83 | 204 | 23% | 52.6% | $126.83 | $73.18 | 0 |
| Apr 16, 2027 | 95.00 | $23.13 | 204 | 23% | 52.6% | $118.13 | $71.88 | 0 |
| Apr 16, 2027 | 90.00 | $20.43 | 204 | 23% | 51.4% | $110.43 | $69.58 | 0 |
| Apr 16, 2027 | 105.00 | $31.73 | 204 | 23% | 51.2% | $136.73 | $73.28 | 0 |
| Jan 15, 2027 | 90.00 | $17.20 | 113 | 23% | 51.2% | $107.20 | $72.80 | 1 |
| Dec 18, 2026 | 90.00 | $16.43 | 85 | 23% | 50.3% | $106.43 | $73.58 | 0 |
| Apr 16, 2027 | 85.00 | $18.55 | 204 | 23% | 49.6% | $103.55 | $66.45 | 0 |
| Apr 16, 2027 | 87.50 | $19.95 | 204 | 23% | 49.2% | $107.45 | $67.55 | 0 |
| Jan 15, 2027 | 82.50 | $13.70 | 113 | 23% | 48.9% | $96.20 | $68.80 | 3 |
| Oct 16, 2026 | 75.00 | $5.15 | 22 | 23% | 48.9% | $80.15 | $69.85 | 0 |
As of September 25, 2026
Find the right straddle before volatility moves
Track LIVN straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→